A stent is a type of medical device that is used to keep a blocked route open. It functions as a small conduit to restore blood and other fluid flow to various body organs. Stents can be made of metal or plastic. Stents, sometimes referred to as the largest stents, are used to clear blockages in larger arteries. Drugs are applied to it to aid in the closure of clogged arteries. Additionally, stents are utilized to stop aneurysms from rupturing blood vessels such as the brain, aorta, or others. 

Market Drivers: The market is expanding due to investments made by businesses that are committed to creating novel technologies and gaining regulatory approvals, which increase the number of advanced stent choices available and encourage broader adoption. For instance, S3V Vascular Technologies invested USD 30 million in Hyderabad, India, in March 2022 to produce pharmaceutical-eluting stents and bioresorbable vascular scaffolds, among other vital cardiac and neuromedical devices. It is anticipated that the aging population and technological developments in stent materials will accelerate market expansion. One in six people on the planet will be 60 or older by 2030, according to WHO projections, which would increase the demand for stents because of age-related diseases such coronary artery disease and atherosclerosis. Stents are essential for restoring normal blood flow and opening constricted arteries. 

Challenges: A number of challenges could impede the growth of the stents industry. The primary barrier is the high expense of stent procedures, which might restrict patient access, especially in developing nations. The complexity of the procedures and the sophisticated technologies utilized in drug-eluting stents are frequently linked to this high cost. Concerns about the possible dangers and side effects of stent implantation, including restenosis (artery re-narrowing), thrombosis (blood clot formation), and the requirement for long-term medication, can also deter patients and medical professionals from choosing stent treatments. Strict regulatory approval procedures present another difficulty and may cause novel stent products to be delayed from reaching the market.

By Region:  In 2024, North America was the market leader for stents, and this trend is expected to continue for the remainder of the projection. This is due to a number of factors, including the rise in stent product approvals, the prevalence of cardiovascular illnesses, the existence of significant stent manufacturers, the expansion of healthcare infrastructure, and technical advancements in the region's healthcare sector. However, because of increasing healthcare expenditures, a shift toward unhealthy lifestyles, an aging population, and the prevalence of coronary heart disease, the Asia-Pacific region is anticipated to grow at the quickest rate during the projected period.

Abbott Laboratories, B. Braun Melsungen AG, BD, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Medtronic Plc, Meril Life Science, MicroPort Scientific Corporation, Stryker, Terumo Corporation, W.L Gore & Associates, and Others.

By Product: Based on the Product, Global Stents Market is segmented as; Coronary Stents, Peripheral Stents, Stent Related Implant.

By Material: Based on the Material, Global Stents Market is segmented as; Metallic Biomaterial, Polymer Biomaterial, Natural Biomaterial.

By End Use: Based on the End Use, Global Stents Market is segmented as; Hospital, Ambulatory Surgical Centers, Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.